Publications | Lund University Publications

21 – 26 of 26

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+%22hema-mha%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor+exact+%22hema-mha%22)&q=subject+exact+%2230203%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
next »

2016
Mark Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden
Borg, Sixten ^LU ; Nahi, Hareth ; Hansson, Markus ^LU ; Lee, Dawn ; Elvidge, Jamie and Persson, Ulf (2016) In Acta Oncologica 55(5). p.554-560
- Contribution to journal › Article
Mark Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma
Moreau, Philippe ; Masszi, T. ; Grzasko, N. ; Bahlis, N. J. ; Hansson, Markus ^LU ; Pour, L. ; Sandhu, I. ; Ganly, P. ; Baker, B. W. and Jackson, S. R. , et al. (2016) In New England Journal of Medicine 374(17). p.1621-1634
- Contribution to journal › Article
2015
Mark Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
Roghanian, Ali ; Teige, Ingrid ^LU ; Mårtensson, Linda ^LU ; Cox, Kerry L ; Kovacek, Mathilda ^LU ; Ljungars, Anne ; Mattson, Jenny ^LU ; Sundberg, Annika ; Vaughan, Andrew T and Shah, Vallari , et al. (2015) In Cancer Cell 27(4). p.473-488
- Contribution to journal › Article
Mark A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.
Hansson, Markus ^LU ; Gimsing, Peter ; Badros, Ashraf Z ; Martinsson Niskanen, Titti ; Nahi, Hareth ; Offner, Fritz ; Salomo, Morten ; Sonesson, Elisabeth ; Mau-Sorensen, Morten and Stenberg, Yvonne , et al. (2015) In Clinical Cancer Research 21(12). p.2730-2736
- Contribution to journal › Article
2014
Mark Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma.
Dimopoulos, M A ; Leleu, X ; Palumbo, A ; Moreau, P ; Delforge, M ; Cavo, M ; Ludwig, H ; Morgan, G J ; Davies, F E and Sonneveld, P , et al. (2014) In Leukemia 28(8). p.1573-1585
- Contribution to journal › Scientific review
2013
Mark A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.
Veitonmäki, Niina ; Hansson, Markus ^LU ; Zhan, Fenghuang ; Sundberg, Annika ; Löfstedt, Tobias ^LU ; Ljungars, Anne ; Li, Zhan-Chun ; Martinsson-Niskanen, Titti ; Zeng, Ming and Yang, Ye , et al. (2013) In Cancer Cell 23(4). p.502-515
- Contribution to journal › Article

« previous
1
2
3
next »

your query:: Remove author: Hansson, Markus (LU); Remove subject: Cancer and Oncology